Table 2a.

Cancer incidence and mortality among women by diagnosis groups, Greenland, 1983–2014.

	Incidence				Mortality
Diagnosis groups	N	N (%)	ASR (W)	IRR (95% CI)	N	%	ASR (W)	MRR (95% CI)
Lip, oral cavity and pharynx	116	4.9	15	3.9 (2.8–5.5)	81	5.3	10	9.9 (5.6–17.4)
Respiratory organs	447	18.9	61	3.2 (2.7–3.8)	438	28.6	61	4.0 (3.3–4.7)
Gastrointestinal organs	540	22.9	73	1.7 (1.5–1.9)	404	26.4	54	2.0 (1.9–2.4)
Urinary tract	62	2.6	8	0.8 (0.6–1.0)	42	2.7	6	1.5 (1.0–2.1)
Female genital organs	431	18.2	49	1.3 (1.2–1.5)	198	12.9	25	1.9 (1.6–2.3)
Breast	354	15.0	42	0.6 (0.5–0.6)	127	8.3	16	0.9 (0.8–1.1)
Melanoma of skin	16	0.7	2	0.1 (0.1–0.2)	2	0.1	0	0.2 (0.1–0.2)
Lymphoma and leukaemia	73	3.1	9	0.4 (0.4–0.5)	34	2.2	4	0.6 (0.4–0.7)
Other specified sites	144	6.1	18	0.8 (0.7–0.9)	46	3.0	6	0.9 (0.7–1.2)
Unknown	179	7.6	24	3.3 (2.5–4.2)	160	10.4	22	3.8 (2.9–5.1)
Total	2362	100.0	301	1.2 (1.1–1.2)	1532	100.0	204	2.1 (1.9–2.2)

N = Numbers of cancer incidence and mortality.

N (%) = the percentage of the numbers of cancer incidence and mortality.

ASR (W) = Age standardized rates for the world, per 100,000 person years.

IRR: Incidence rate-ratios, with 95% confidence intervals, relative to the rates in the other Nordic countries.

MRR: Mortality rate-ratios, with 95% confidence intervals, relative to the rates in the other Nordic countries.

95% CI: 95% confidence intervals.